These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

509 related items for PubMed ID: 32950951

  • 1. Isoliquiritigenin attenuates diabetic cardiomyopathy via inhibition of hyperglycemia-induced inflammatory response and oxidative stress.
    Gu X, Shi Y, Chen X, Sun Z, Luo W, Hu X, Jin G, You S, Qian Y, Wu W, Liang G, Wu G, Chen Z, Chen X.
    Phytomedicine; 2020 Nov; 78():153319. PubMed ID: 32950951
    [Abstract] [Full Text] [Related]

  • 2. An Aza resveratrol-chalcone derivative 6b protects mice against diabetic cardiomyopathy by alleviating inflammation and oxidative stress.
    You S, Qian J, Sun C, Zhang H, Ye S, Chen T, Xu Z, Wang J, Huang W, Liang G.
    J Cell Mol Med; 2018 Mar; 22(3):1931-1943. PubMed ID: 29327811
    [Abstract] [Full Text] [Related]

  • 3. Blockage of ROS and NF-κB-mediated inflammation by a new chalcone L6H9 protects cardiomyocytes from hyperglycemia-induced injuries.
    Zhong P, Wu L, Qian Y, Fang Q, Liang D, Wang J, Zeng C, Wang Y, Liang G.
    Biochim Biophys Acta; 2015 Jul; 1852(7):1230-41. PubMed ID: 25736300
    [Abstract] [Full Text] [Related]

  • 4. Luteolin protects against diabetic cardiomyopathy by inhibiting NF-κB-mediated inflammation and activating the Nrf2-mediated antioxidant responses.
    Li L, Luo W, Qian Y, Zhu W, Qian J, Li J, Jin Y, Xu X, Liang G.
    Phytomedicine; 2019 Jun; 59():152774. PubMed ID: 31009852
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic cardiomyopathy in rats.
    Luo J, Yan D, Li S, Liu S, Zeng F, Cheung CW, Liu H, Irwin MG, Huang H, Xia Z.
    J Cell Mol Med; 2020 Jan; 24(2):1760-1773. PubMed ID: 31856386
    [Abstract] [Full Text] [Related]

  • 9. The investigation of potential mechanism of Fuzhengkangfu Decoction against Diabetic myocardial injury based on a combined strategy of network pharmacology, transcriptomics, and experimental verification.
    Li M, Chen L, Liu X, Wu Y, Chen X, Chen H, Zhong Y, Xu Y.
    Biomed Pharmacother; 2024 Aug; 177():117048. PubMed ID: 38959606
    [Abstract] [Full Text] [Related]

  • 10. Klotho protects the heart from hyperglycemia-induced injury by inactivating ROS and NF-κB-mediated inflammation both in vitro and in vivo.
    Guo Y, Zhuang X, Huang Z, Zou J, Yang D, Hu X, Du Z, Wang L, Liao X.
    Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):238-251. PubMed ID: 28982613
    [Abstract] [Full Text] [Related]

  • 11. Sinapic acid ameliorates cardiac dysfunction and cardiomyopathy by modulating NF-κB and Nrf2/HO-1 signaling pathways in streptozocin induced diabetic rats.
    Raish M, Ahmad A, Bin Jardan YA, Shahid M, Alkharfy KM, Ahad A, Ansari MA, Abdelrahman IA, Al-Jenoobi FI.
    Biomed Pharmacother; 2022 Jan; 145():112412. PubMed ID: 34768051
    [Abstract] [Full Text] [Related]

  • 12. Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice.
    Yu M, Liu Y, Zhang B, Shi Y, Cui L, Zhao X.
    Cardiovasc Pathol; 2015 Jan; 24(6):375-81. PubMed ID: 26164195
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Aspalathin Protects the Heart against Hyperglycemia-Induced Oxidative Damage by Up-Regulating Nrf2 Expression.
    Dludla PV, Muller CJ, Joubert E, Louw J, Essop MF, Gabuza KB, Ghoor S, Huisamen B, Johnson R.
    Molecules; 2017 Jan 14; 22(1):. PubMed ID: 28098811
    [Abstract] [Full Text] [Related]

  • 15. Matrine pretreatment improves cardiac function in rats with diabetic cardiomyopathy via suppressing ROS/TLR-4 signaling pathway.
    Liu ZW, Wang JK, Qiu C, Guan GC, Liu XH, Li SJ, Deng ZR.
    Acta Pharmacol Sin; 2015 Mar 14; 36(3):323-33. PubMed ID: 25619390
    [Abstract] [Full Text] [Related]

  • 16. SIRT6‑specific inhibitor OSS‑128167 exacerbates diabetic cardiomyopathy by aggravating inflammation and oxidative stress.
    Huang Y, Zhang J, Xu D, Peng Y, Jin Y, Zhang L.
    Mol Med Rep; 2021 May 14; 23(5):. PubMed ID: 33760202
    [Abstract] [Full Text] [Related]

  • 17. The antioxidant edaravone prevents cardiac dysfunction by suppressing oxidative stress in type 1 diabetic rats and in high-glucose-induced injured H9c2 cardiomyoblasts.
    Ji L, Liu Y, Zhang Y, Chang W, Gong J, Wei S, Li X, Qin L.
    Can J Physiol Pharmacol; 2016 Sep 14; 94(9):996-1006. PubMed ID: 27376621
    [Abstract] [Full Text] [Related]

  • 18. Hinokinin alleviates high fat diet/streptozotocin-induced cardiac injury in mice through modulation in oxidative stress, inflammation and apoptosis.
    Lu Q, Zheng R, Zhu P, Bian J, Liu Z, Du J.
    Biomed Pharmacother; 2021 May 14; 137():111361. PubMed ID: 33761596
    [Abstract] [Full Text] [Related]

  • 19. Apocynin attenuates diabetic cardiomyopathy by suppressing ASK1-p38/JNK signaling.
    Ding W, Feng H, Li WJ, Liao HH, Zhang N, Zhou ZY, Mou SQ, Lin Z, Xia-He NZ, Xia H, Tang QZ.
    Eur J Pharmacol; 2021 Oct 15; 909():174402. PubMed ID: 34348125
    [Abstract] [Full Text] [Related]

  • 20. Effects of resveratrol on regulation on UCP2 and cardiac function in diabetic rats.
    Diao J, Wei J, Yan R, Fan G, Lin L, Chen M.
    J Physiol Biochem; 2019 Feb 15; 75(1):39-51. PubMed ID: 30225723
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.